No abstract available
MeSH terms
-
Animals
-
Antineoplastic Agents / therapeutic use*
-
Benzamides
-
Binding Sites
-
Cell Division / drug effects
-
Clinical Trials as Topic
-
Combined Modality Therapy
-
Drug Resistance
-
Enzyme Inhibitors / therapeutic use*
-
Fusion Proteins, bcr-abl / metabolism
-
Hematopoietic Stem Cell Transplantation
-
Humans
-
Hydroxyurea / therapeutic use
-
Imatinib Mesylate
-
Interferon-alpha / therapeutic use
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / metabolism
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
-
Middle Aged
-
Models, Molecular
-
Piperazines / chemical synthesis
-
Piperazines / pharmacology
-
Piperazines / therapeutic use*
-
Protein Kinase Inhibitors
-
Pyrimidines / chemical synthesis
-
Pyrimidines / pharmacology
-
Pyrimidines / therapeutic use*
-
Structure-Activity Relationship
-
Tumor Cells, Cultured / drug effects
Substances
-
Antineoplastic Agents
-
Benzamides
-
Enzyme Inhibitors
-
Interferon-alpha
-
Piperazines
-
Protein Kinase Inhibitors
-
Pyrimidines
-
Imatinib Mesylate
-
Fusion Proteins, bcr-abl
-
Hydroxyurea